BCL2 and familial pancreatic carcinoma: Moreover, exogenous HMGB1 can activate p-GSK 3β through the Wnt signaling pathway, upregulate the expression of Bcl-2 and Ki67, and downregulate the expression of E-CA in pancreatic cancer cells, thus fostering the proliferation of pancreatic cancer cells [34].